# First in Human Phase 1 Ascending Dose Study of PanChol in Healthy Volunteers

> **NCT05657782** · PHASE1 · UNKNOWN · sponsor: **Brigham and Women's Hospital** · enrollment: 53 (estimated)

## Conditions studied

- Cholera
- Cholera Vaccine Toxicity

## Interventions

- **BIOLOGICAL:** PanChol

## Key facts

- **NCT ID:** NCT05657782
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-12-12
- **Primary completion:** 2024-12-01
- **Final completion:** 2025-12-01
- **Target enrollment:** 53 (ESTIMATED)
- **Last updated:** 2022-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05657782

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05657782, "First in Human Phase 1 Ascending Dose Study of PanChol in Healthy Volunteers". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05657782. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*